|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3466949 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18192207.1 |
| Date of filing the European patent application | 2014-12-23 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation | 2021-03-25 |
| (30) | Number | Date | Country code |
| 201361920500 P | 2013-12-24 | US |
| (72) |
NORRIS, Derek J., US
DELUCCA, George V., US
GAVAI, Ashvinikumar V., US
QUESNELLE, Claude A., US
GILL, Patrice, US
O`MALLEY, Daniel, US
VACCARO, Wayne, US
LEE, Francis Y., US
DEBENEDETTO, Mikkel V., US
DEGNAN, Andrew P., US
FANG, Haiquan, US
HILL, Matthew D., US
HUANG, Hong, US
SCHMITZ, William D., US
STARRETT, JR, John E., US
HAN, Wen-Ching, US
TOKARSKI, John S., US
MANDAL, Sunil Kumar, IN
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Triciklinis junginys kaip priešvėžinis agentas |
| TRICYCLIC COMPOUND AS ANTICANCER AGENTS |
| Payment date | Validity (years) | Amount | |
| 2024-11-25 | 11 | 289.00 EUR |
| 2025-12-23 |